Ivermectin is best known for its antiparasitic properties. Yet, the drug also has antiviral and anti-inflammatory properties. Studies have shown that ivermectin helps to lower the viral load by inhibiting replication. A single dose of ivermectin can kill 99.8% of the virus within 48 hours.
Škoda mojega časa debatirati s tabo in ostalimi.
Vse vam prinesem na pladnju. Vse kar zmorete je posmehovanje (konjska pasta) in delanje norca (primerjanje s Cedevito in ostalimi debilizmi), zraven pa se ne zavedate, da pljuvate v lastno skledo in da ste to počeli dobro leto.
Problem je, da je ta pladenj precej ubog. Npr. tvoj zgornji prispevek o ivermectinu in molecular docking je vsebinsko totalno sranje (pa je mi je jasno da je to preprint, ki so ga eni nadebudni znanstveniki objavili).
Bi se dalo napisat cel esej, kjer bi lahko od črtice do črtice razložil, zakaj je arXiv preprint Insights from a computational analysis of the SARS-CoV-2 Omicron variant: Host-pathogen interaction, pathogenicity and possible therapeutics zmazek (ampak je res škoda mojega časa).
Ti dam en izziv, koliko se spoznaš, a lahko (brez googla) streseš iz rokava slovenski prevod za molecular docking pa scoring function.
Imaš prav. Zato še malo nalimaj, kar copy/paste. Ti pričakuješ, da bomo mi zabili pol ure časa, da bomo tvoje copy/pastane neumnosti (za kar rabiš 1 sekundo) debunkali. Lepo te prosim. Da bom ob 2.00 zjutraj delal in jamral, kako moram deleat cele dneve. Lool.Škoda mojega časa debatirati s tabo in ostalimi.
Vse vam prinesem na pladnju. Vse kar zmorete je posmehovanje (konjska pasta) in delanje norca (primerjanje s Cedevito in ostalimi debilizmi), zraven pa se ne zavedate, da pljuvate v lastno skledo in da ste to počeli dobro leto.
Ena izmed uveljavljenih možnosti (nimam pojma, kaj je konkretno uporabljal Eli Lilly)Povej še na kakšen način je bila ugotovljena (ne)učinkovitost monokloidnih protiteles proti Omicronu, da so izgubila EUA.
Ne more, nima več, iverca skurila vse.Daj, vklopi malo možgane.
Ne more, nima več, iverca skurila vse.
Pa kaj se sploh še bockate z bolnikom.
Meni je edino žal, da ga ne morem dati na ignore, ker je pač moderator. Vse ostale njegove somišljenike sem že pred časom poklikal na ignore
Mogoče pa ima samo gliste, ta stara.Ocitno je Ivermectin skuril tudi mozgane kraljici in njenim zdravnikom:
Is the Queen, like 200 members of the US Congress, secretly using Ivermectin to treat Covid?
Horse paste for your Queen?twoplustwoequalsfournews.wordpress.com
Sej vam bo enkrat kapnilo. Enkrat.
Ocitno je Ivermectin skuril tudi mozgane kraljici in njenim zdravnikom:
Abstract: We retrospectively identified adults (≥18 years) with a recorded COVID-19 infection between January 1, 2020 and July 11, 2021. We compared those with recorded use of ivermectin, but not remdesivir, against those with recorded use of remdesivir, but not ivermectin. We controlled for the following demographics, comorbidities, and treatments that may affect COVID-19 survival outcomes: age, gender, race, ethnicity, nicotine use diabetes mellitus, obesity, chronic lower respiratory disease, ischemic heart diseases, tocilizumab, glucocorticoids, or ventilator use. We measured association with mortality as the primary outcome, with significance assessed at p<0.05.
Results: There were a total of 1,761,060 possible COVID-19 patients based on ICD-10 diagnostic terms and confirmatory lab results. Prior to controlling, our analysis yielded 41,608 patients who had COVID-19 resulting in two unique cohorts that were treated with either ivermectin (1,072) or remdesivir (40,536). Within the ivermectin cohort, average age was 51.9 + 17.8 years, 43% were male, 60% had glucocorticoids and 1% required ventilator support. In the remdesivir cohort, average age was 62.0 + 16.0 years, 54% were male, 64% had glucocorticoids and 2% required ventilator support. After using propensity score matching and adjusting for potential confounders, ivermectin was associated with reduced mortality vs remdesivir (OR 0.308, 95% CI (0.198,0.479)),Risk Difference -5.224%, CI (-7.079%,-3.369%), p <0.0001.
Conclusion: Ivermectin use was associated with decreased mortality in patients with COVID-19 compared to remdesivir. To our knowledge, this is the largest association study of patients with COVID-19, mortality and ivermectin. Further double-blinded placebo-controlled RCTs with large samples are required for definite conclusion. In the future, if more publications are published with the similar result to the current analyses, the certainty of evidence will increase.